Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. [electronic resource]
Producer: 20020212Description: 548-53 p. digitalISSN:- 0020-7136
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- blood
- Carcinoma -- blood
- Cisplatin -- administration & dosage
- False Positive Reactions
- Female
- Fluorouracil -- administration & dosage
- Follow-Up Studies
- Humans
- Keratins -- analysis
- Life Tables
- Male
- Middle Aged
- Nasopharyngeal Neoplasms -- blood
- Neoplasm Metastasis
- Neoplasm Proteins -- analysis
- Polymorphism, Restriction Fragment Length
- Predictive Value of Tests
- Prognosis
- Prospective Studies
- Pseudogenes
- RNA, Messenger -- blood
- RNA, Neoplasm -- blood
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Analysis
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.